GS
Gurjeet Singh Bedi
About Gurjeet Singh Bedi
Data last updated:
Gurjeet Singh Bedi is an Additional Director at Baxter Pharmaceuticals India Private Limited (since 2024). The company operates in Pharma. Baxter Pharmaceuticals India Private Limited reported revenue of ₹672 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Baxter Pharmaceuticals India Private Limited U24230GJ2005PTC046211 | Additional Director | 23 Dec 2024 | 2005 | ₹672 Cr (FY 2025) | Active |
Board colleagues of Gurjeet Singh Bedi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Bharatkumar Pachchigar | 10776295 | Baxter Pharmaceuticals India Private Limited | Additional Director |
| Anuranjan Naresh | 02822684 | Baxter Pharmaceuticals India Private Limited | Additional Director |
| Ashwin Prakash Upasane | 11132124 | Baxter Pharmaceuticals India Private Limited | Additional Director |
| Sanju Dhawan | 09224741 | Baxter Pharmaceuticals India Private Limited | Director |
| Tripti Sapra | 10776278 | Baxter Pharmaceuticals India Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurjeet Singh Bedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurjeet Singh Bedi
Gurjeet Singh Bedi currently holds 1 directorship: Baxter Pharmaceuticals India Private Limited (Additional Director, since 23 Dec 2024, revenue ₹672 Cr (FY 2025)).
Gurjeet Singh Bedi was first appointed on 23 Dec 2024 as Additional Director at Baxter Pharmaceuticals India Private Limited.
The current boards of Gurjeet Singh Bedi's companies include Anurag Bharatkumar Pachchigar (Baxter Pharmaceuticals India Private Limited), Anuranjan Naresh (Baxter Pharmaceuticals India Private Limited), Ashwin Prakash Upasane (Baxter Pharmaceuticals India Private Limited), Sanju Dhawan (Baxter Pharmaceuticals India Private Limited), Tripti Sapra (Baxter Pharmaceuticals India Private Limited).